CIBC Asset Management Inc Grows Stock Holdings in Humana Inc. $HUM

CIBC Asset Management Inc boosted its position in Humana Inc. (NYSE:HUM) by 69.4% in the 4th quarter, Holdings Channel reports. The fund owned 28,501 shares of the insurance provider’s stock after purchasing an additional 11,679 shares during the period. CIBC Asset Management Inc’s holdings in Humana were worth $7,300,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Illinois Municipal Retirement Fund raised its position in shares of Humana by 9.6% in the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after buying an additional 4,351 shares during the last quarter. Long Focus Capital Management LLC acquired a new stake in Humana during the third quarter worth about $34,212,000. AMG National Trust Bank increased its position in Humana by 106.5% during the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after purchasing an additional 8,744 shares during the last quarter. Aberdeen Group plc increased its position in Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after purchasing an additional 43,442 shares during the last quarter. Finally, Alberta Investment Management Corp acquired a new stake in Humana during the third quarter worth about $4,735,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Up 0.0%

HUM stock opened at $349.85 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $351.88. The company’s 50 day moving average is $248.43 and its two-hundred day moving average is $232.40. The stock has a market cap of $42.00 billion, a P/E ratio of 37.42, a PEG ratio of 2.00 and a beta of 0.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter last year, the company earned $11.58 earnings per share. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts expect that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Analyst Upgrades and Downgrades

HUM has been the subject of several recent analyst reports. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Truist Financial raised their price objective on shares of Humana from $270.00 to $320.00 and gave the stock a “hold” rating in a research report on Monday. Needham & Company LLC initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating for the company. UBS Group raised their price objective on shares of Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. Finally, Raymond James Financial restated an “outperform” rating and set a $260.00 price objective on shares of Humana in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, fourteen have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $279.30.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.